The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
Opens in a new tab or window The FDA approved insulin-aspart-szjj ... The approval is for both a 3 mL single-patient-use prefilled pen and a 10 mL multiple-dose vial. "For the millions of people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback